FDA announces major reforms to streamline biosimilar approvals, potentially saving Americans billions on prescription drug ...

Trump administration officials pledged Monday that major reforms for biosimilar drug approvals will expand access and lower ...

In a significant policy move to make advanced treatments more affordable, the U.S. Food and Drug Administration (FDA) has ...

Drug Approval Process Training Course (Feb 23rd - Feb 24th, 2026)" training has been added to ResearchAndMarkets.com's offering. The US is the largest market globally for pharmaceutical sales, so ...

FDA Policy Changes Could Bring Some Biosimilars To Market Faster. Legal News and Analysis - USA - Intellectual Property - Conventus Law ...

The FDA on Thursday awarded six new Commissioner’s National Priority Vouchers for a variety of conditions including lung cancer, rectal cancer and weight loss.

Luca Maini, assistant professor of health care policy in the Blavatnik Institute at Harvard Medical School, studies ...

President Donald Trump announced Thursday morning that Novo Nordisk and Eli Lilly have agreed to lower the price of two ...

Sandoz said the acquisition will give it the capabilities for the development and manufacturing of biosimilars using ...

With its biosimilars business thriving, Amgen isn’t a fan of changes proposed by HHS Secretary Robert F. Kennedy Jr. | With its biosimilars business thriving, Amgen isn’t a fan of changes proposed by ...

Pharmacist and PhD researcher Hannah Cleary tells us about her work on long-acting injectables (LAIs) to improve drug ...

Hengrui, one of China's leading pharmaceutical companies, is preparing to bring its cancer therapies to international markets ...